PC-SOD or placebo will be given to patients as an i.v. infusion before chemotherapy

2 trials

Sponsors

Mizushima Tohru

Conditions

Chemotherapy induced peripheral neuropathy (CIPN)

Phase 2

Phase II study of PC-SOD for chemotherapy-induced peripheral neuropathy

Active, not recruitingJPRN-jRCT2031210466

Mizushima TohruChemotherapy induced peripheral neuropathy (CIPN)

Start: 2022-01-19Target: 80Updated: 2026-06-29

Phase II study of PC-SOD for Chemotherapy-induced peripheral neuropathy in ovarian cancer patients

Active, not recruitingJPRN-jRCT2031240306

Mizushima TohruChemotherapy induced peripheral neuropathy (CIPN)

Start: 2024-08-30Target: 80Updated: 2026-06-29

Related Papers

A phase 3, randomized, double-blind, placebo-controlled study of lecithinized superoxide dismutase (PC-SOD) for the prevention of chemotherapy-induced peripheral neuropathy in patients with colorectal cancer receiving adjuvant mFOLFOX6 therapy (PROSPER study).

Journal of Clinical Oncology2026-01-10